Literature DB >> 12433445

Preparation and characterization of chitosan microparticles intended for controlled drug delivery.

J A Ko1, H J Park, S J Hwang, J B Park, J S Lee.   

Abstract

Chitosan microparticles were prepared with tripolyphosphate (TPP) by ionic crosslinking. The particle sizes of TPP-chitosan microparticles were in range from 500 to 710 microm and encapsulation efficiencies of drug were more than 90%. The morphologies of TPP-chitosan microparticles were examined with scanning electron microscopy. As pH of TPP solution decreased and molecular weight (MW) of chitosan increased, microparticles had more spherical shape and smooth surface. Release behaviors of felodipine as a model drug were affected by various preparation processes. Chitosan microparticles prepared with lower pH or higher concentration of TPP solution resulted in slower felodipine release from microparticles. With decreasing MW and concentration of chitosan solution, release behavior was increased. The release of drug from TPP-chitosan microparticles decreased when cross-linking time increased. These results indicate that TPP-chitosan microparticles may become a potential delivery system to control the release of drug.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12433445     DOI: 10.1016/s0378-5173(02)00487-8

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  51 in total

1.  Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles.

Authors:  Jing Chen; Wu-Li Yang; Ge Li; Ji Qian; Jing-Lun Xue; Shou-Kuan Fu; Da-Ru Lu
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

2.  Two-stage optimization process for formulation of chitosan microspheres.

Authors:  Rajesh R Dubey; Rajesh H Parikh
Journal:  AAPS PharmSciTech       Date:  2004-02-06       Impact factor: 3.246

3.  An approach for lacidipine loaded gastroretentive formulation prepared by different methods for gastroparesis in diabetic patients.

Authors:  Shaheen Sultana; Sushama Talegaonkar; Devender Singh; Riyaz Ahmad; Venu Manukonda; Aseem Bhatnagar; F J Ahmad
Journal:  Saudi Pharm J       Date:  2013-04-17       Impact factor: 4.330

4.  Controlling chitosan-based encapsulation for protein and vaccine delivery.

Authors:  Bhanu Prasanth Koppolu; Sean G Smith; Sruthi Ravindranathan; Srinivas Jayanthi; Thallapuranam K Suresh Kumar; David A Zaharoff
Journal:  Biomaterials       Date:  2014-02-21       Impact factor: 12.479

5.  Assessment of improved buccal permeation and bioavailability of felodipine microemulsion-based cross-linked polycarbophil gel.

Authors:  Mahendra Singh; Jovita Kanoujia; Poonam Parashar; Malti Arya; Chandra B Tripathi; V R Sinha; Shailendra K Saraf; Shubhini A Saraf
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

6.  pH-Triggered Magnetic-Chitosan Nanogels (MCNs) For Doxorubicin Delivery: Physically vs. Chemically Cross Linking Approach.

Authors:  Somayeh Sadighian; Hassan Hosseini-Monfared; Kobra Rostamizadeh; Mehrdad Hamidi
Journal:  Adv Pharm Bull       Date:  2015-03-05

7.  Ionic Cross-linked Chitosan Beads for Extended Release of Ciprofloxacin: In vitro Characterization.

Authors:  A Srinatha; J K Pandit; S Singh
Journal:  Indian J Pharm Sci       Date:  2008-01       Impact factor: 0.975

Review 8.  Marine polysaccharides in pharmaceutical applications: an overview.

Authors:  Paola Laurienzo
Journal:  Mar Drugs       Date:  2010-09-02       Impact factor: 5.118

9.  Spray-dried chitosan microparticles for cellular delivery of an antigenic protein: physico-chemical properties and cellular uptake by dendritic cells and macrophages.

Authors:  Chirasak Kusonwiriyawong; Vimolmas Lipipun; Nontima Vardhanabhuti; Qiang Zhang; Garnpimol C Ritthidej
Journal:  Pharm Res       Date:  2013-03-13       Impact factor: 4.200

10.  In vitro and in vivo studies on chitosan beads of losartan Duolite AP143 complex, optimized by using statistical experimental design.

Authors:  Ashwini Madgulkar; Mangesh Bhalekar; Megha Swami
Journal:  AAPS PharmSciTech       Date:  2009-06-03       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.